Lupin has received USFDA approval for Clomipramine Hydrochloride capsules and Potassium Chloride for oral solution. The drug will be made available in the strengths of […]
Lupin has received USFDA approval for Atovaquone Oral Suspension USP, 750 mg/5 million. The drug is the generic version of GlaxoSmithKline LLC’s Mepron Oral Suspension, […]
Lupin has launched Potassium Chloride Oral Solution USP, 20 mEq/15mL (10 per cent) and 40 mEq/15 mL (20 per cent) in the US markets. The […]
Lupin has received USFDA approval to market Drospirenone, Ethinyl Estradiol, Levomefolate Calcium tablets in the American market. The drug is a generic version of Bayer […]
Lupin has signed an agreement with CSIR-National Chemical Laboratory (CSIR-NCL, Pune) and Department of Science and Technology, (DST, Delhi) for conducting research on a continuous […]
Lupin Ltd has received final USFDA approval for its generic version of Dovonex scalp solution used in treatment of psoriasis of scalp. The drug calcipotriene […]
Lupin has received final USFDA approval to market generic Nadolol tablets, used for treatment of hypertension, in the American market. The drug will be marketed […]
Lupin Ltd has received final USFDA approval to market a generic version of County Line Pharmaceuticals, LLC’s Fluocinonide Topical Solution. The solution is used to […]
Lupin has received final USFDA approval to market a generic version of Novartis’ inhalation product Tobi, which is used to treat cystic fibrosis, in the […]
Lupin Ltd has received final USFDA approval to market sodium sulfate, potassium sulfate, magnesium sulfate oral solution used in colonoscopy. The company will market sodium […]
Copyright © 2025 | WordPress Theme by MH Themes